TrialJAMA network open2020

Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Evan Kovac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.